Abstract
The COVID-19 pandemic prompted many scientists to investigate remedies against SARS-CoV-2 and related viruses that are likely to appear in the future. As the main protease of the virus, M-Pro , is highly conserved among coronaviruses, it has emerged as a prime target for developing inhibitors. Using a combination of virtual screening and molecular modeling, we identified small molecules that were easily accessible and could be quickly diversified. Biochemical assays confirmed a class of pyridones as low micromolar noncovalent inhibitors of the viral main protease.
| Dokumententyp: | Zeitschriftenartikel | 
|---|---|
| Fakultät: | Chemie und Pharmazie > Department Chemie | 
| Themengebiete: | 500 Naturwissenschaften und Mathematik > 540 Chemie | 
| ISSN: | 0936-5214 | 
| Sprache: | Englisch | 
| Dokumenten ID: | 98100 | 
| Datum der Veröffentlichung auf Open Access LMU: | 05. Jun. 2023 15:27 | 
| Letzte Änderungen: | 05. Jun. 2023 15:27 | 
		
	